## Abstract Methylene blue (MB), a widely studied reagent, is investigated in this work for its usage in photodynamic therapy (PDT). PDT has been proved to be highly effective in the treatment of different types of cancers. Previous studies showed MB has both high affinity for mitochondria and high
Methylene Blue-Conjugated Hydrogel Nanoparticles and Tumor-Cell Targeted Photodynamic Therapy
β Scribed by Hoe Jin Hah; Gwangseong Kim; Yong-Eun Koo Lee; Daniel A. Orringer; Oren Sagher; Martin A. Philbert; Raoul Kopelman
- Book ID
- 102933904
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 744 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1616-5187
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Methylene blueβconjugated polyacrylamide nanoparticles are prepared through a microemulsion polymerization, after conjugation of the dye with a monomer. The nanoparticles have a 50β60βnm diameter in solution. This conjugation method enables a large increase in loading of methylene blue per nanoparticle and also minimizes dye leaching out of the nanoparticle. Furthermore, the dye content can be controlled by variation of the dye amount, enabling a more refined control of the singlet oxygen production ability. The nanoparticles are coated with F3 peptides, which give specific targeting to selected tumor cells, 9L, MDAβMBβ435, and F98, in vitro. In addition, MTT assays reveal that the nanoparticles have no dark toxicity but excellent PDT efficacy increasing with the nanoparticle dose and irradiation time. magnified image
π SIMILAR VOLUMES
## Abstract ## Background and Objectives We examined tumor response to methylene blue (MB)βmediated photodynamic therapy (PDT) in a murine tumor model. The goal was to investigate the effects of drugβlight interval (DLI), injection vehicle, and fluence on tumor destruction. Fluorescence and reflec